Financials

  • Market Capitalization 624.94 M
  • Employee 146
  • Founded 2019
  • CEO N/A
  • Website www.primemedicine.com
  • Headquarter Delaware, United States
  • FIGI BBG011RT3R55
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.57
ratio cours/chiffre d'affaires
111.44

Prime Medicine, Inc. - Common Stock

Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.

Nouvelles